KMTS
Kestra Medical Technologies Stock Analysis
AI Rating
- Quality5/10
- Growth↓ 2/10
- Value↓ 0/10
KMTS Growth
- Revenue Y/Y↑ 59.06%
- EPS Y/Y↑ 30.54%
- FCF Y/Y↓ -35.51%
KMTS Profitability
- Gross margin ↑ 48.80%
- EPS margin↓ -176.90%
- ROIC 5Y↓ 0.00%
KMTS Risk
- Debt / Equity↓ 0.2
- Debt / FCF↓ 0.0
- Interest coverage↓ -18.3
Kestra Medical Technologies stock volatility is in-line with the overall market. We give it a Great risk rating.